Ovoca Bio | OVG - Marktkapitalisierung

Aktienkurs
8.25
Täglich Wechseln
0.25 3.13%
Monatlich
-2.94%
Jährlich
120.00%
Q2 Prognose
7.04




Marktkapitalisierung Veränderung Datum
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
ALKERMES USD 4.62B 333M 2025-12
Avita Medical AUD 105.47M 35.32M 2025-12
Dianthus Therapeutics USD 1.78B 215M 2025-12
Great Western Mining Corporation EUR 1.42M 490.37K 2026-04
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Malin Corporation EUR 142.92M 19.65M 2026-02
Organon & Co USD 1.86B 916.43M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Revvity USD 10.97B 1.21B 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Viatris USD 14.34B 2.8B 2025-12
Xeris Pharmaceuticals USD 1.3B 12M 2025-12